http://rdf.ncbi.nlm.nih.gov/pubchem/patent/TW-394758-B
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_65fa8e578edfc4736f5e8b9a49caf5e8 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C57-40 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-19 |
| filingDate | 1994-12-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2000-06-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ba61d5c2b4ded9293db0b3fe09817707 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6a431fb633c631ee5a1b9932782be7af http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5441ed3f13a5962db637445f8bf8664a |
| publicationDate | 2000-06-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | TW-394758-B |
| titleOfInvention | Naphthyloxyacetic acid |
| abstract | (1) Naphthyloxyaetic acid represented by the compound of the formula (1), and non-toxic salts thereof, (2) process for the preparation of the compounds represented by the compound of the formula (1) described hereinbefore, (3) PGE2 antagonist or agonist containing the compound represented by the compound of the formula (1) as the active ingredient. The compounds represented by the compounds of the formula (1) can be adapted to medicines which possess an inhibitory effect of uterine contraction, an analgetic action, an inhibitory effect of digestive peristalsis, a sleep-inducing effect as PGE2 antagonists, and uterine contractile activity, a promoting effect of digestive peristalsis, a suppressive effect of gastric acid secretion, hypotensive activity as PGE 2 agonists, because they bind onto PGE2 receptor and have antagonist or agonist activity against the action thereof. |
| priorityDate | 1994-12-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 162.